Maxlinear (MXL) Stake Maintained by Firsthand Capital Management Inc; As Cara Therapeutics (CARA) Share Value Rose, Holder Kerrisdale Advisers Decreased Stake by $466,427

February 18, 2018 - By reb123z

Sahm Adrangi decreased its stake in Cara Therapeutics Inc (CARA) by 71.76% based on its latest 2017Q3 regulatory filing with the SEC. Kerrisdale Advisers Llc sold 35,879 shares as the company’s stock rose 14.02% with the market. The hedge fund run by Sahm Adrangi held 14,121 shares of the health care company at the end of 2017Q3, valued at $193,000, down from 50,000 at the end of the previous reported quarter. Kerrisdale Advisers Llc who had been investing in Cara Therapeutics Inc for a number of months, seems to be less bullish one the $472.17 million market cap company. The stock decreased 2.43% or $0.36 during the last trading session, reaching $14.48. About 767,150 shares traded. Cara Therapeutics, Inc. (NASDAQ:CARA) has risen 206.00% since February 18, 2017 and is uptrending. It has outperformed by 189.30% the S&P500.

Firsthand Capital Management Inc increased its stake in Maxlinear Inc. (MXL) by 150% based on its latest 2017Q3 regulatory filing with the SEC. Firsthand Capital Management Inc bought 30,000 shares as the company’s stock rose 16.78% with the market. The institutional investor held 50,000 shares of the technology company at the end of 2017Q3, valued at $1.19M, up from 20,000 at the end of the previous reported quarter. Firsthand Capital Management Inc who had been investing in Maxlinear Inc. for a number of months, seems to be bullish on the $1.53B market cap company. The stock decreased 0.74% or $0.17 during the last trading session, reaching $22.89. About 546,654 shares traded or 2.13% up from the average. MaxLinear, Inc. (NYSE:MXL) has risen 63.31% since February 18, 2017 and is uptrending. It has outperformed by 46.61% the S&P500.

Since January 24, 2018, it had 0 insider purchases, and 2 insider sales for $412,500 activity. Shares for $225,000 were sold by Menzaghi Frederique Ph.D. on Wednesday, January 24.

Analysts await Cara Therapeutics, Inc. (NASDAQ:CARA) to report earnings on March, 8. They expect $-0.39 earnings per share, up 51.85% or $0.42 from last year’s $-0.81 per share. After $-0.38 actual earnings per share reported by Cara Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 2.63% negative EPS growth.

Kerrisdale Advisers Llc, which manages about $371.12M and $95.80M US Long portfolio, upped its stake in Luxoft Hldg Inc (NYSE:LXFT) by 459,033 shares to 765,514 shares, valued at $36.59 million in 2017Q3, according to the filing.

Among 10 analysts covering Cara Therapeutics (NASDAQ:CARA), 10 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Cara Therapeutics had 24 analyst reports since July 27, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Thursday, October 13 by H.C. Wainwright. The rating was maintained by H.C. Wainwright with “Buy” on Thursday, July 13. The stock of Cara Therapeutics, Inc. (NASDAQ:CARA) earned “Buy” rating by Needham on Wednesday, June 21. The firm earned “Buy” rating on Friday, August 4 by H.C. Wainwright. Needham maintained it with “Buy” rating and $27 target in Friday, July 24 report. Cantor Fitzgerald initiated the shares of CARA in report on Wednesday, November 4 with “Buy” rating. As per Wednesday, June 21, the company rating was maintained by Stifel Nicolaus. The stock of Cara Therapeutics, Inc. (NASDAQ:CARA) has “Buy” rating given on Thursday, August 3 by Stifel Nicolaus. Canaccord Genuity maintained the shares of CARA in report on Friday, August 4 with “Buy” rating. The firm has “Buy” rating given on Friday, June 30 by Laidlaw.

Investors sentiment decreased to 0.85 in Q3 2017. Its down 0.76, from 1.61 in 2017Q2. It fall, as 22 investors sold CARA shares while 31 reduced holdings. 20 funds opened positions while 25 raised stakes. 17.83 million shares or 4.68% less from 18.71 million shares in 2017Q2 were reported. Glenmede Na holds 0% or 250 shares in its portfolio. Vantage Investment Advisors Limited Liability Company accumulated 1,700 shares. Bridgeway Cap Management has invested 0.01% in Cara Therapeutics, Inc. (NASDAQ:CARA). Parametric Associate Ltd Liability Corporation holds 0% in Cara Therapeutics, Inc. (NASDAQ:CARA) or 33,521 shares. 38,600 are held by Alliancebernstein Limited Partnership. C Wide Gp A S owns 291,341 shares or 0.06% of their US portfolio. Art Limited Liability Corporation stated it has 189,600 shares or 0.13% of all its holdings. Cambridge Invest Advsr has 20,896 shares. Creative Planning reported 0% in Cara Therapeutics, Inc. (NASDAQ:CARA). Susquehanna Interest Grp Llp accumulated 131,540 shares. Bluecrest Mngmt holds 10,938 shares. Moreover, State Board Of Administration Of Florida Retirement Sys has 0% invested in Cara Therapeutics, Inc. (NASDAQ:CARA). Credit Suisse Ag owns 0% invested in Cara Therapeutics, Inc. (NASDAQ:CARA) for 50,084 shares. Sg Americas Secs Ltd Liability stated it has 25,353 shares. Tci Wealth Advisors reported 175 shares.

Investors sentiment decreased to 1.18 in Q3 2017. Its down 0.19, from 1.37 in 2017Q2. It fall, as 37 investors sold MXL shares while 43 reduced holdings. 25 funds opened positions while 69 raised stakes. 54.60 million shares or 2.82% more from 53.10 million shares in 2017Q2 were reported. Art Advsrs Ltd Liability Co accumulated 21,595 shares. Rothschild Asset Mgmt Incorporated holds 0.02% or 82,624 shares. Price T Rowe Associates Inc Md stated it has 2.50M shares. State Street Corporation, a Massachusetts-based fund reported 1.85M shares. Panagora Asset Mngmt reported 301,648 shares. Victory Capital Mngmt Inc accumulated 0% or 92,402 shares. Ahl Llp, a United Kingdom-based fund reported 31,412 shares. Moreover, Ngam Advisors LP has 0.04% invested in MaxLinear, Inc. (NYSE:MXL). Blackrock holds 0.01% or 7.32M shares. Blair William & Com Il invested in 0.08% or 474,055 shares. Sterling Capital Management Ltd Liability Corporation has 0.02% invested in MaxLinear, Inc. (NYSE:MXL). Deutsche Bankshares Ag reported 287,305 shares stake. 8,446 were reported by Affinity Invest Llc. Qs Invsts Ltd Liability Corporation holds 0.03% or 176,141 shares. Sg Americas Secs Ltd Com invested in 41,561 shares.

Since January 9, 2018, it had 0 insider purchases, and 1 sale for $700,554 activity.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts